Pfizer said Thursday it wants to expand its COVID-19 booster shots to healthy elementary-age kids. US health authorities already urge everyone 12 and older to get one booster dose for the best safety against the newest variants.
In a deal that will strengthen its emphasis on the delivery of drugs, Halozyme Therapeutics Inc. offered to acquire specialised biopharmaceutical business Antares Pharma Inc. for roughly 1 billion dollars.
Akums Drugs & Pharmaceuticals Ltd has newly acquired a facility from Ankur Drugs and Pharmaceuticals Limited.
India's pharmaceutical companies will get an easy access to launch their products in the Australian market, with Therapeutic Goods Administration the drug regulatory authority in Australia agreeing to expedite faster and easier approvals for India's
Britain’s GlaxoSmithKline has agreed to buy California-based biopharmaceutical firm Sierra Oncology in a cash deal valued at $1.9 billion, the companies said on Wednesday, as it seeks to bolster its blood cancer business.
Developing pharmaceuticals through lengthy and costly clinical trials is definitely an approach which is here since long.
Zydus Lifesciences announced that it will be producing and supplying Sagent’s caffeine citrate oral solution in the strength of 60 mg per 3 mL (20 mg per mL) Single-dose Vial (US RLD: CAFCIT) from its injectables facility at Jarod, Gujarat.
Pharmaceutical major Lupin is looking to step up its presence in India, with its hiring connected to new business divisions being launched.
Alembic Pharmaceuticals Limited (Alembic) today declared its wholly-owned subsidiary, Aleor Dermaceuticals Limited (Aleor) has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application
Britain will increase access to Pfizer's oral antiviral COVID-19 treatment to thousands more people by adding it to a trial to assess how best to use the drug in its highly vaccinated population, the health ministry said on Tuesday
, CDSCO.jpg)
